{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:59:18Z","timestamp":1789106358691,"version":"build-2803163510"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.5414\/cp203767","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T14:53:10Z","timestamp":1598280790000},"page":"703-708","source":"Crossref","is-referenced-by-count":7,"title":["Role of eosinophilic chronic rhinosinusitis in\u00a0switching to benralizumab treatment in mepolizumab responders"],"prefix":"10.5414","volume":"58","author":[{"given":"Satoshi","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yasuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T13:24:05Z","timestamp":1605187445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=187193&doi=10.5414\/CP203767&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"alternative-id":["203767"],"URL":"https:\/\/doi.org\/10.5414\/cp203767","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}